United Kingdom· GB-APID-40770611000001108
Scemblix 40mg tablets
A asciminib product containing asciminib, registered in United Kingdom by Novartis Pharmaceuticals UK Ltd. The same ATC class is registered in 16 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Asciminib is registered in 16 of 19 countries.
Countries holding a registration under ATC L01EA06 (asciminib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Asciminib · ATC L01EA06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of asciminib costs, country by country.
Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.27 in France to $162.23 in Switzerland — a ×606 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Asciminib · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- CH Switzerland$162.23
- FR France$0.27
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Asciminib
- Manufacturer
- Novartis Pharmaceuticals UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EA06
- ATC class
- Asciminib
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin7613421057510
- gtin7613421105365
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Asciminib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaSCEMBLIXNOVARTIS PHARMACEUTICALS CANADA INC
- CzechiaSCEMBLIXNovartis Europharm Limited, Dublin
- SwitzerlandScemblix 100 mg, FilmtablettenNovartis Pharma Schweiz AG
- United StatesSCEMBLIXNovartis Pharmaceuticals Corporation
- IcelandScemblixNovartis Europharm Limited*
- NetherlandsScemblix 100 mg, filmomhulde tabletNovartis Europharm Limited
- SwedenScemblix 100 mg Filmdragerad tablettNovartis Europharm Limited
- BelgiumScemblix 100 mgNovartis Europharm
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Scemblix
- Liechtenstein · Scemblix
- Norway · Scemblix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5241e7b-04d7-4310-b801-26cae8f61d70 GET /v1/drugs/e5241e7b-04d7-4310-b801-26cae8f61d70?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40770611000001108",
"desc": "Scemblix 40mg tablets (Novartis Pharmaceuticals UK Ltd)",
"form": "Oral tablet",
"vpid": "40585011000001104",
"source": "dmd",
"vtm_id": "40580211000001100",
"strength": "40 mg",
"substance": "Asciminib",
"ingredient": "Asciminib hydrochloride",
"supplier_code": "2920101000001102"
}See everything about asciminib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.